Thrombotic Disorders

Baker Jr WF. Thrombolytic therapy clinical application. Hematol Oncol Clin North Am 2003;17:283-311.

Bick RL. Antiphospholipid thrombosis syndrome. Hematol Oncol Clin North Am 2003;17:115-47.

Bick RL. Prothrombin G 20210A mutation, heparin cofactor II, protein C and protein S defects. Hematol Oncol Clin North Am 2003;17:9-36.

Crowter MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis. A qualitative overview and proposed classification system. Ann Intern Med 2003;138:128-34.

Hoppe C, Matsunaga A. Pediatric thrombosis. Pediatr Clin North Am 2002; 49:1257-83.

Kwann HC, Nabhan C. Hereditary and acquired defects in the fibrinolytic system associated with thrombosis. Hematol Oncol Clin North Am 2003;17:103-14.

Levine JS, Branch W, Rauch J. Antiphospholipid syndrome. New Engl J Med 2002;346:752-63.

Meinardi JR, Middeldorp S, De Kam PJ, et al. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant throm-bophilic disorders. Brit J Haematol 2002;116:625-33.

Selighsohn U, Lubertsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.

Whiteman T, Hassouna H I. Hypercoagulable states. Hematol Oncol Clin North Am 2000;14:355-77.

Was this article helpful?

0 0

Post a comment